Generation of RRMS and PPMS specific iPSCs as a platform for modeling Multiple Sclerosis-Reference-Cited by-同舟云学术

Generation of RRMS and PPMS specific iPSCs as a platform for modeling Multiple Sclerosis

Published:2021-05 Issue: Volume:53 Page:102319
ISSN:1873-5061
Container-title:Stem Cell Research
language:en
Short-container-title:Stem Cell Research

Author:

Mutukula Naresh,Man Zhiqiu,Takahashi Yuta,Iniesta Martinez Francisca,Morales Mariana,Carreon-Guarnizo Ester,Hernandez Clares Rocio,Garcia-Bernal David,Martinez Martinez Llanos,Lajara Jeronimo,Nuñez Delicado Estrella,Meca Lallana Jose E.,Izpisua Belmonte Juan Carlos

Funder

Moxie Foundation

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,General Medicine

Reference49 articles.

1. Progressive multiple sclerosis: pathology and pathogenesis;Lassmann;Nat Rev Neurol.,2012

2. Multiple sclerosis;Compston;Lancet.,2008

3. Relapses and progression of disability in multiple sclerosis;Confavreux;N Engl J Med.,2000

4. Franklin RJ, ffrench-Constant C, Edgar JM, Smith KJ. Neuroprotection and repair in multiple sclerosis. Nat Rev Neurol. 2012 Nov 5;8(11):624-34. doi: 10.1038/nrneurol.2012.200. Epub 2012 Oct 2. PMID: 23026979.

5. Defining the clinical course of multiple sclerosis: the 2013 revisions;Lublin;Neurology,2014

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Induced Pluripotent Stem Cells and Organoids in Advancing Neuropathology Research and Therapies;Cells;2024-04-25

2. Research progress of autoimmune diseases based on induced pluripotent stem cells;Frontiers in Immunology;2024-04-24

3. Integrative single-cell analysis of neural stem/progenitor cells reveals epigenetically dysregulated interferon response in progressive multiple sclerosis;2024-02-09

4. Increased Cholesterol Synthesis Drives Neurotoxicity in Patient Stem Cell-Derived Model of Multiple Sclerosis;2024-01-16

5. Integrative Single-Cell Analysis of Neural Stem/Progenitor Cells Reveals Epigenetically Dysregulated Interferon Response in Progressive Multiple Sclerosis;2024